|
Sign In to gain access to subscriptions and/or personal tools.
|
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE |
Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections
G. Hajishengallis1,5,
S. Arce2,4,
C.M. Gockel2,4,
T.D. Connell2,4 and
M.W. Russell2,3,4,*
1 Department of Microbiology, Immunology, and Parasitology, and Center of Excellence in Oral and Craniofacial Biology, Louisiana State University Health Sciences Center, New Orleans, LA, USA;
2 Departments of Microbiology and Immunology and
3 Oral Biology,
4 The Witebsky Center for Microbial Pathogenesis and Immunology, University at Buffalo, 3435 Main Street/Farber 138, Buffalo, NY 14214, USA;
Correspondence: * corresponding author, russellm{at}buffalo.edu
The heat-labile enterotoxins, such as cholera toxin (CT), and the labile toxins types I and II (LT-I and LT-II) of Escherichia coli have been extensively studied for their immunomodulatory properties, which result in the enhancement of immune responses. Despite superficial similarity in structure, in which a toxic A subunit is coupled to a pentameric binding B subunit, different toxins have different immunological properties. Administration of appropriate antigens admixed with or coupled to these toxins by oral, intranasal, or other routes in experimental animals induces mucosal IgA and circulating IgG antibodies that have protective potential against a variety of enteric, respiratory, or genital infections. These include the generation of salivary antibodies that may protect against colonization with mutans streptococci and the development of dental caries. However, exploitation of these adjuvants for human use requires an understanding of their mode of action and the separation of their desirable immunomodulatory properties from their toxicity. Recent findings have revealed that adjuvant action is not critically dependent upon the enzymic activity of the A subunits, and that the isolated B subunits may exert different effects on cells of the immune system than do the intact toxins. Interaction of the toxins with immunocompetent cells is not exclusively dependent upon their conventional ganglioside receptors. Immunomodulatory effects have been observed on dendritic cells, macrophages, CD4+ and CD8+ T-cells, and B-cells. Numerous factors—including the precise form of the toxin adjuvant, properties of the antigen, whether and how they are coupled, route of administration, and species of animal model—affect the outcome, whether this is enhanced humoral and cellular immunity, or specific induced tolerance toward the antigen.
Key Words: cholera toxin • heat-labile enterotoxin • vaccine • adjuvant • immune response
Journal of Dental Research, Vol. 84, No. 12,
1104-1116 (2005)
DOI: 10.1177/154405910508401205
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
D. R. M. Negri, D. Pinto, S. Vendetti, M. Patrizio, M. Sanchez, A. Riccomi, P. Ruggiero, G. Del Giudice, and M. T. De Magistris
Cholera Toxin and Escherichia coli Heat-Labile Enterotoxin, but Not Their Nontoxic Counterparts, Improve the Antigen-Presenting Cell Function of Human B Lymphocytes
Infect. Immun.,
May 1, 2009;
77(5):
1924 - 1935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. J. Maldonado-Arocho and K. A. Bradley
Anthrax Edema Toxin Induces Maturation of Dendritic Cells and Enhances Chemotaxis towards Macrophage Inflammatory Protein 3{beta}
Infect. Immun.,
May 1, 2009;
77(5):
2036 - 2042.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Zhou, A. Goodsell, Y. Uematsu, and M. Vajdy
Prolonged Protection against Intranasal Challenge with Influenza Virus following Systemic Immunization or Combinations of Mucosal and Systemic Immunizations with a Heat-Labile Toxin Mutant
Clin. Vaccine Immunol.,
April 1, 2009;
16(4):
471 - 478.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Liang, K. B. Hosur, S. Lu, H. F. Nawar, B. R. Weber, R. I. Tapping, T. D. Connell, and G. Hajishengallis
Mapping of a Microbial Protein Domain Involved in Binding and Activation of the TLR2/TLR1 Heterodimer
J. Immunol.,
March 1, 2009;
182(5):
2978 - 2985.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Mestecky, M. W. Russell, and C. O. Elson
Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier?
J. Immunol.,
November 1, 2007;
179(9):
5633 - 5638.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Liang, M. Wang, K. Triantafilou, M. Triantafilou, H. F. Nawar, M. W. Russell, T. D. Connell, and G. Hajishengallis
The A Subunit of Type IIb Enterotoxin (LT-IIb) Suppresses the Proinflammatory Potential of the B Subunit and Its Ability to Recruit and Interact with TLR2
J. Immunol.,
April 15, 2007;
178(8):
4811 - 4819.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Liang, M. Wang, R. I. Tapping, V. Stepensky, H. F. Nawar, M. Triantafilou, K. Triantafilou, T. D. Connell, and G. Hajishengallis
Ganglioside GD1a Is an Essential Coreceptor for Toll-like Receptor 2 Signaling in Response to the B subunit of Type IIb Enterotoxin
J. Biol. Chem.,
March 9, 2007;
282(10):
7532 - 7542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Arce, H. F. Nawar, G. Muehlinghaus, M. W. Russell, and T. D. Connell
In Vitro Induction of Immunoglobulin A (IgA)- and IgM-Secreting Plasma Blasts by Cholera Toxin Depends on T-Cell Help and Is Mediated by CD154 Up-Regulation and Inhibition of Gamma Interferon Synthesis
Infect. Immun.,
March 1, 2007;
75(3):
1413 - 1423.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. F. Nawar, S. Arce, M. W. Russell, and T. D. Connell
Mutants of Type II Heat-Labile Enterotoxin LT-IIa with Altered Ganglioside-Binding Activities and Diminished Toxicity Are Potent Mucosal Adjuvants
Infect. Immun.,
February 1, 2007;
75(2):
621 - 633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
